Vistapharm patents expiration
1. Thyquidity patents expiration
THYQUIDITY's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9050307 | VISTAPHARM | Method for the preparation of a levothyroxine solution |
Aug, 2031
(7 years from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 30 November, 2020
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of THYQUIDITY before it's drug patent expiration?
More Information on Dosage
THYQUIDITY family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic